NO135067C - - Google Patents

Info

Publication number
NO135067C
NO135067C NO1493/70A NO149370A NO135067C NO 135067 C NO135067 C NO 135067C NO 1493/70 A NO1493/70 A NO 1493/70A NO 149370 A NO149370 A NO 149370A NO 135067 C NO135067 C NO 135067C
Authority
NO
Norway
Application number
NO1493/70A
Other languages
Norwegian (no)
Other versions
NO135067B (fr
Inventor
Jr A J Barnes
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO135067B publication Critical patent/NO135067B/no
Publication of NO135067C publication Critical patent/NO135067C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Clamps And Clips (AREA)
NO1493/70A 1969-04-21 1970-04-20 NO135067C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81805769A 1969-04-21 1969-04-21

Publications (2)

Publication Number Publication Date
NO135067B NO135067B (fr) 1976-10-25
NO135067C true NO135067C (fr) 1977-02-02

Family

ID=25224552

Family Applications (1)

Application Number Title Priority Date Filing Date
NO1493/70A NO135067C (fr) 1969-04-21 1970-04-20

Country Status (9)

Country Link
US (1) US3502663A (fr)
AT (1) AT296503B (fr)
BR (1) BR6914873D0 (fr)
CH (1) CH529789A (fr)
CS (1) CS166256B2 (fr)
ES (1) ES378831A1 (fr)
NO (1) NO135067C (fr)
PL (1) PL80656B1 (fr)
SE (1) SE361044B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL149810B (nl) * 1969-04-21 1976-06-15 Lilly Co Eli Werkwijze ter bereiding van een farmaceutisch preparaat door kristallijn cefalexine in een voor therapeutische toediening geschikte vorm te brengen, gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van voor bovengenoemde toepassing geschikt cefalexine.
GB1317159A (en) * 1969-09-26 1973-05-16 Glaxo Lab Ltd Manufacture of cephalosporin compounds
IT1126544B (it) * 1979-12-07 1986-05-21 Dobfar Spa Procedimento per la preparazione di derivati dell'acido 7-amino-desacetossi cefalosporanico
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US5278157A (en) * 1989-07-10 1994-01-11 Gema, S.A. Stable cephradine hydrate
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate

Also Published As

Publication number Publication date
SE361044B (fr) 1973-10-15
CH529789A (de) 1972-10-31
CS166256B2 (fr) 1976-02-27
PL80656B1 (en) 1975-08-30
NO135067B (fr) 1976-10-25
AT296503B (de) 1972-02-25
US3502663A (en) 1970-03-24
ES378831A1 (es) 1973-01-16
BR6914873D0 (pt) 1973-03-08

Similar Documents

Publication Publication Date Title
AU2270770A (fr)
DK129458C (fr)
CS149924B2 (fr)
AU465413B2 (fr)
AU450150B2 (fr)
NO135067C (fr)
AU2355770A (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU442538B2 (fr)
AU442554B2 (fr)
AU442535B2 (fr)
AU470661B1 (fr)
AT308690B (fr)
AU442463B2 (fr)
AU4949169A (fr)
CS151209B1 (fr)
CS148846B1 (fr)
AU4540468A (fr)
AU5109569A (fr)
AU1036070A (fr)
AU5077469A (fr)
AR203167Q (fr)
AU5066368A (fr)
BE754560A (fr)